Remove tag health-information
article thumbnail

Grand Rounds February 2, 2024: Strategies for Improving Public Understanding of FDA and the Products It Regulates…Why Should We Care, and What Might We Do? (Susan C. Winckler, RPh, Esq)

Rethinking Clinical Trials

Food and Drug Administration, FDA, Misinformation, Communication, Health Information Key Points U.S. From January to September 2023, the Foundation conducted in-depth research and held 5 listening sessions to learn how people consume and understand health information.

article thumbnail

Grand Rounds October 13, 2023: Incorporating Social Determinants of Health Into PCORnet (Keith Marsolo, PhD)

Rethinking Clinical Trials

Speaker Keith Marsolo, PhD Associate Professor Department of Population Health Sciences Duke University School of Medicine Slides Keywords PCORnet, Common Data Model, EHR, Social Determinants of Health Key Points There are many different definitions of social determinants of health. For example, consider food security.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds January 26, 2024: Advancing the Safe, Effective and Equitable Use of AI in Healthcare (Mark Sendak, MD, MPP; Suresh Balu, MD, MBA)

Rethinking Clinical Trials

DIHI approaches this work through four pillars of innovation: implementation and health delivery science, health technology innovation, leadership and workforce development, and best practices development and dissemination. The Health AI Partnership started with 7 organization partners and has expanded to about 20 organizations.

article thumbnail

Grand Rounds Ethics and Regulatory Series November 11, 2022: Data Sharing and Pragmatic Clinical Trials: Law & Ethics Amidst a Changing Policy Landscape (Stephanie Morain, PhD, MPH; Kayte Spector-Bagdady, JD, MBioethics)

Rethinking Clinical Trials

Berman Institute of Bioethics & Johns Hopkins Bloomberg School of Public Health. The guidance has been updated over the years, and in 2020 NIH came out with the final iteration that goes into effect in January 2023 that applies to any research funded in whole or in part by NIH to maximize data sharing through the informed consent process.

article thumbnail

Grand Rounds March 1, 2024: Effect of an Intensive Food-As-Medicine Program on Health and Health Care Use: Evidence from a Randomized Clinical Trial (Joseph Doyle, PhD)

Rethinking Clinical Trials

Food-as-Medicine observational studies have had a large correlation with improved health. Clinic staff included a dietitian, a nurse and a community health worker. Additional data sources came from EHR data, health plan claims, and program participation data including food visits and education.

article thumbnail

Grand Rounds October 28, 2022: The HERO (Healthcare Worker Exposure Response & Outcomes) Program: An Online Community to Support Observational Studies, Randomized Trials, and Long-Term Safety Surveillance (Emily O’Brien, PhD, FAHA; Russell Rothman, MD, MPP)

Rethinking Clinical Trials

Department of Population Health Sciences. Senior Vice President, Population and Public Health. Director, Vanderbilt Institute for Medicine and Public Health. – The HERO Registry survey collected a large broad range of information. Associate Professor. Duke Clinical Research Institute. Russell Rothman, MD, MPP.

Trials 130
article thumbnail

Scientists and medics turn to TikTok to reassure public on vaccine safety

pharmaphorum

Tik Tok is unlikely to spring to mind as a source of reliable information about complex issues, but scientists are using it to fly the flag for COVID-19 vaccines and other health topics. When we talk about vaccines as health professionals, people who are vehemently anti-vaccine can take it out of context for their agenda.